SCHEMBL6763704

SCHEMBL6763704

CS(=O)(=O)NCCOc1ccc2cc(CCNS(C)(=O)=O)ccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
HTT P42858 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ROCK2 O75116 2/20 0.49
MAP4K4 O95819 2/20 0.49
PIM1 P11309 2/20 0.49
PRKACA P17612 2/20 0.49
CDK2 P24941 2/20 0.49
GSK3B P49841 2/20 0.49
HIPK2 Q9H2X6 2/20 0.49
DYRK3 O43781 1/20 0.49
PRKD3 O94806 1/20 0.49
CDK1 P06493 1/20 0.49
ROS1 P08922 1/20 0.49
RPS6KB1 P23443 1/20 0.49
AKT1 P31749 1/20 0.49
CLK2 P49760 1/20 0.49
IRAK1 P51617 1/20 0.49
RPS6KA3 P51812 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763717 0.92 ALDH1A1 (0.44) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6763747 0.91 ALDH1A1 (0.47) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6763745 0.91 GRIA4 (0.48) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6571967 0.91 PTGS2 (0.45) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6762788 0.90 CA1 (0.45) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6762092 0.89 HTT (0.66) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL6759300 0.89 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6761044 0.88 ALDH1A1 (0.49) ALDH1A1HTTMEN1KMT2AROCK2
SCHEMBL6763749 0.87 PPARG (0.63) HTTMEN1KMT2ASLC2A1SMN1; SMN2
SCHEMBL6571852 0.85 PTGS2 (0.66) ALDH1A1PTGS2SLC2A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 ALDH1A1 365/4885HTT 1694/4885MEN1 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.